News Acip Recommends Use of Mercks Enflonsia for Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants Younger Than 8 Months of Age Born During or Entering Their First Rsv Season
A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
News Acip Recommends Use of Mercks Enflonsia for Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants Younger Than 8 Months of Age Born During or Entering Their First Rsv Season